Experiment 152657

Worktypes

PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

STREPTOMYCES ANTIBIOTIC EC-40

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
LIPID PEROXIDE FORMATION INHIBITION
OrganismStreptomyces chrestomyceticus (STREPTOMYCETACEAE)
CitationKATO,S: KAWAI,H:. (1992). NOVEL PHYSOLOGICALLY ACTIVE SUBSTANCE EC40.. ()
Amount utilized
Compound isolated
DiseasePEROXYLIPID FORMATION WAS INHIBITED 81.5%.
Dose amount0.1 MILLIMOLS
Number2
Qualitative resultACTIVE
Dose expressionCONC USED